| 000 | 01502 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513152526.0 | ||
| 264 | 0 | _c19981022 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0016-5085 | ||
| 024 | 7 |
_a10.1016/s0016-5085(98)70254-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBar-Meir, S | |
| 245 | 0 | 0 |
_aBudesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group. _h[electronic resource] |
| 260 |
_bGastroenterology _cOct 1998 |
||
| 300 |
_a835-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aBudesonide _xadverse effects |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChowers, Y | |
| 700 | 1 | _aLavy, A | |
| 700 | 1 | _aAbramovitch, D | |
| 700 | 1 | _aSternberg, A | |
| 700 | 1 | _aLeichtmann, G | |
| 700 | 1 | _aReshef, R | |
| 700 | 1 | _aOdes, S | |
| 700 | 1 | _aMoshkovitz, M | |
| 700 | 1 | _aBruck, R | |
| 700 | 1 | _aEliakim, R | |
| 700 | 1 | _aMaoz, E | |
| 700 | 1 | _aMittmann, U | |
| 773 | 0 |
_tGastroenterology _gvol. 115 _gno. 4 _gp. 835-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0016-5085(98)70254-9 _zAvailable from publisher's website |
| 999 |
_c9718388 _d9718388 |
||